Datar Cancer Genetics

Datar Cancer Genetics

The No Risk
Blood Based


The Problem Statement

Cancer diagnosis is often through biopsies which are invasive and may not be completely accurate. There is often a lot of anxiety, pain, risk and costs associated with invasive biopsies for the diagnosis of cancer.

Usual Tissue Biopsy/FNAC

Revolutionary non-invasive, cost-effective, safe and accurate blood test that can be used in most suspected cases of solid tumors and brain tumors instead of an invasive biopsy. The test is conducted on peripheral blood and involves a simple blood draw. The results are available in 10-12 days.

Key Benefits of Non-Invasive Diagnosis

Large clinical studies to back up performance

The performance of test is supported by rigorous clinical studies with more than 40,000 participants representing diverse populations.1,2



We’re here to assist you

If you have any questions or want to learn more, please contact us.

1Akolkar et al, Circulating ensembles of tumor-associated cells: A redoubtable new systemic hallmark of cancer,
2Ranade et al, Hallmark Circulating Tumor-Associated Cell Clusters Signify 230 Times Higher One-Year Cancer Risk. Cancer Prev Res (Phila). 2021 Jan;14(1):11-16. doi: 10.1158/1940-6207.CAPR-20-0322. Epub 2020 Sep 21. PMID: 32958586.